Streptozocin + 5‐FU (1 RCT; 20 participants)
It is very uncertain whether estimates of effects, ranking, and certainty of evidence for… changes streptozocin + 5‐FU (1 RCT; 20 participants) compared with placebo (very low certainty).
1 finding from 1 review
OR 0.13 [0, 4.58]
1 study · 5 participants
Very low
Total studies: 9 Total participants: 1311Â
1 finding from 1 review
no estimate extracted
9 participants
GRADE not reported
Prostate cancer incidence · adults (aged at least 18 years)
Green tea extract supplementation showed no clear difference in prostate cancer incidence compared with placebo (low certainty).
1 finding from 1 review
Gynaecological cancer incidence · adults (aged at least 18 years)
Green tea extract supplementation showed no clear difference in gynaecological cancer incidence compared with placebo (low certainty).
1 finding from 1 review
Non‐melanoma skin cancer incidence · adults (aged at least 18 years)
Green tea extract supplementation showed no clear difference in non‐melanoma skin cancer incidence compared with placebo (low certainty).
1 finding from 1 review
Quality of life · adults (aged at least 18 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall survival ‐ first‐line studies · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in overall survival ‐ first‐line studies compared with placebo or standard of care (moderate certainty).
1 finding from 1 review
Overall survival ‐ recurrent disease studies · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in overall survival ‐ recurrent disease studies compared with placebo or standard of care (low certainty).
1 finding from 1 review
Lymphopenia · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in lymphopenia compared with placebo or standard of care (low certainty).
1 finding from 1 review
Neutropenia · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in neutropenia compared with placebo or standard of care (low certainty).
1 finding from 1 review
Thrombocytopenia · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in thrombocytopenia compared with placebo or standard of care (low certainty).
1 finding from 1 review
Progression‐free survival · glioblastoma in adults
Anti‐EGFR therapy showed no clear difference in progression‐free survival ‐ first‐line studies compared with placebo or standard of care (low certainty).
1 finding from 1 review
Progression‐free survival ‐ recurrent disease studies · glioblastoma in adults
Anti‐EGFR therapy may leads to lower progression‐free survival ‐ recurrent disease studies compared with placebo or standard of care (low certainty).
1 finding from 1 review
Rate of symptom relief · women previously treated for endometrial cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rate of tumour recurrence · women previously treated for endometrial cancer
It is very uncertain whether oestrogen replacement therapy changes rate of tumour recurrence compared with placebo (very low certainty).
1 finding from 1 review
Rate of appearance of a new malignancy · women previously treated for endometrial cancer
It is very uncertain whether oestrogen replacement therapy changes rate of appearance of a new malignancy compared with placebo (very low certainty).
1 finding from 1 review
Rate of survival: overall survival · women previously treated for endometrial cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Progression‐free survival (PSF) · women previously treated for endometrial cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea · participants with cancer treated with radiotherapy (with or without chemotherapy)
1 finding from 1 review
Diarrhoea · participants with cancer treated with chemotherapy
Probiotics may leads to lower any diarrhoea compared with placebo (low certainty).
1 finding from 1 review